Index removals put fresh attention on Markel Group stock

Markel Group (MKL) has just been removed from several Russell Growth and Midcap benchmarks, a technical event that can force index-tracking funds to rebalance and potentially shift short term trading flows.

At the same time, Markel Group continues to attract interest as a specialty insurance and investment business. The index deletions raise questions about how much of the recent share price action reflects fundamentals versus mechanical selling.

Against this backdrop, Markel Group's recent share price moves have been mixed, with the share price falling 1.86% over the last day but posting a 7.09% 1 month share price return. The 5 year total shareholder return of 53.72% contrasts with weaker year to date and 1 year outcomes as index removals and earnings news reshape sentiment.

If these index changes have you reassessing your watchlist, it could be a good moment to broaden your search and check out 20 top founder-led companies

With Markel Group trading at a small discount to recent analyst targets and an estimated 8.15% intrinsic discount, the key question is whether current weakness offers value or whether the market is already pricing in future growth.

Preferred P/E of 13.7x: Is it justified for Markel Group?

On a simple P/E comparison, Markel Group stock looks expensive, with a 13.7x P/E against an estimated fair P/E of 11.7x and a US insurance peer average of 12.2x.

The P/E ratio compares the share price with earnings per share, so a higher P/E usually means investors are paying more today for each dollar of current earnings.

For Markel Group, a 13.7x P/E alongside earnings that are forecast to grow 3.79% per year and an 8.15% intrinsic discount from the SWS DCF model suggests the market may be pricing in only moderate profit growth while still accepting a premium. The fair P/E of 11.7x is meaningfully lower than where the stock trades. This signals a level the market could move toward if sentiment or growth expectations cool.

Compared with the broader US Insurance industry average P/E of 11.8x, Markel Group is on a richer multiple, and it also screens as expensive versus the 12.2x peer average. That is a clear premium for a company whose revenue is forecast to grow 3.8% per year, slower than both the US market and the sector.

Result: Price-to-earnings of 13.7x (OVERVALUED)

However, Markel Group's relatively rich P/E, alongside forecasts for only mid single digit revenue and earnings growth, plus its wide mix of non insurance businesses, could challenge the premium.

Another view on Markel Group's value

The P/E work suggests Markel Group trades at a premium, yet the SWS DCF model points the other way. With the stock at $1,916.64 and the model estimating future cash flow value at $2,086.77, that implies Markel Group is trading at about an 8.2% discount. Which signal do you put more weight on?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Markel Group for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 41 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If the mixed signals on Markel Group leave you unsure, this is a good time to review the numbers yourself, consider your position carefully, and explore the 2 key rewards

Looking for more investment ideas beyond Markel Group?

If Markel Group has sharpened your focus on quality, do not stop here. Fresh ideas often come from widening your search just when others narrow theirs.

• Target potential mispricings by scanning 41 high quality undervalued stocks that pair solid fundamentals with prices that may not fully reflect their financial profile.
• Strengthen your income stream by reviewing 8 dividend fortresses that combine higher yields with an emphasis on durability.
• Protect your downside by assessing 73 resilient stocks with low risk scores that score well on balance sheet strength and overall risk signals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.